天然产物
多元化(营销策略)
合成生物学
药物发现
计算生物学
生物
非核糖体肽
生化工程
药物开发
生物技术
药品
业务
生物化学
工程类
生物合成
药理学
酶
营销
作者
Sean B. Romanowski,Alessandra S. Eustáquio
标识
DOI:10.1016/j.cbpa.2020.09.006
摘要
Natural products continue to provide privileged scaffolds for drug discovery. However, challenges in supply and structure diversification can limit development. Here, we discuss recent (2017–2020) examples of synthetic biology approaches used to address challenges in supply and contribute to structure diversification of selected plant and bacterial natural products. Our examples include plant terpenoids, alkaloids, and lignans and bacterial polyketides, nonribosomal peptides, and ribosomally synthesized and posttranslationally modified peptides.
科研通智能强力驱动
Strongly Powered by AbleSci AI